Literature DB >> 21749191

Coping behaviour following traumatic brain injury: what makes a planner plan and an avoider avoid?

Katherine M Krpan1, Donald T Stuss, Nicole D Anderson.   

Abstract

PRIMARY
OBJECTIVE: Avoidant coping has consistently been related to negative outcomes following traumatic brain injury (TBI), although the mechanisms of this relationship are not clear. A recent study demonstrated that people with moderate-to-severe TBI engaged in more avoidant than planful coping behaviour during a psychosocial stress test, while their matched healthy counterparts engaged in the opposite pattern. The purpose of the current study was to evaluate the neuropsychological, physiological and psychological differences between planners and avoiders with TBI. METHODS AND PROCEDURES: Eighteen people with moderate-to-severe TBI completed the Baycrest Psychosocial Stress Test (BPST) where coping behaviour was evaluated and physiological measures recorded. Participants also completed a series of questionnaires and a neuropsychological test battery. MAIN OUTCOMES AND
RESULTS: Compared to avoiders, planners had better executive function, were more psychologically and physiologically reactive and performed better on the BPST. Dysfunction on tests assessing executive abilities was the best predictor of avoidant coping, while physiological and psychological reactivity were the best predictors of planful coping.
CONCLUSIONS: This study is the first to document differences between planners and avoiders with TBI. Understanding the determinants of coping following TBI will allow for more sophisticated and targeted rehabilitative intervention.

Entities:  

Mesh:

Year:  2011        PMID: 21749191     DOI: 10.3109/02699052.2011.597045

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  1 in total

1.  Factor structure and item level psychometrics of the Social Problem Solving Inventory-Revised: Short Form in traumatic brain injury.

Authors:  Chih-Ying Li; Julia Waid-Ebbs; Craig A Velozo; Shelley C Heaton
Journal:  Neuropsychol Rehabil       Date:  2015-06-08       Impact factor: 2.868

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.